Coherus Biosciences | CHRS - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
AbbVie USD 14.39B 1.85B 2026-06
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
Akebia Therapeutics USD 47.28M 1.7M 2025-12
ALKERMES USD 375.31M 43.98M 2026-06
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amarin USD 23.17M 961K 2025-12
Amgen USD 5.87B 1.02B 2026-03
Baxter International USD 1.14B 251M 2026-06
Biogen USD 2.12B 307M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Coherus Biosciences USD 8.7M 853K 2025-12
Eli Lilly USD 16.22B 301.7M 2026-03
Fujifilm JPY 376.67B 29.16B 2026-03
Gilead Sciences USD 6.8B 1.29B 2026-06
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Merck USD 12.09B 1.24B 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Pacira USD 133.91M 7.27M 2026-06
Perrigo USD 313.9M 11.6M 2026-06
Pfizer USD -248M 11.29B 2026-06
PTC Therapeutics USD 232.94M 84.56M 2026-03
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Teva Pharmaceutical Industries USD 2.15B 45M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06
Xencor USD 51.22M 46.7M 2026-06
Zoetis USD 1.76B 140M 2026-06